Enzon Pharmaceuticals, Inc.

ENZN

OTC

Healthcare

Biotechnology

Cranford, NJ, USenzon.com

—

At a Glance

AI-generated

8-K

On March 26, 2026, Viskase Holdings, Inc. (formerly Enzon Pharmaceuticals, Inc.) completed its merger with Viskase Companies, Inc., making Viskase a wholly owned subsidiary that converted to an LLC. The company changed its name, appointed new executives and directors, issued shares to IEH affiliates and Viskase shareholders, and began trading under temporary symbol ENZND on OTCQB.

—

Market Cap

—

Revenue

—

Net Income

Fundamentals

How The Business Makes Money

Enzon Pharmaceuticals, Inc., together with its subsidiaries, engages in marketing drug products. The company's marketed drug product is PegIntron. It also has a marketing agreement relating to Vicineum drug. The company was founded in 1981 and is headquartered in Cranford, New Jersey.

Industry Biotechnology

Activity

What Changed Recently

Material Agreement

Mar 10, 2026

Entry into a Material Definitive Agreement. On March 10, 2026, Enzon Pharmaceuticals, Inc. (the “ Company ”) entered into the Ninth Amendment to the Section 382

Material Agreement

Feb 26, 2026

Entry into a Material Definitive Agreement. On February 27, 2026, Enzon Pharmaceuticals, Inc. (the “ Company ”) entered into the Eighth Amendment to the Section

Material Agreement

Jan 29, 2026

Entry into a Material Definitive Agreement. On January 30, 2026, Enzon Pharmaceuticals, Inc. (the “ Company ”) entered into the Seventh Amendment to the Section

Asset Acquisition+5 More

Mar 25, 2026

of this Current Report, which are hereby incorporated herein by reference. Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. C

Regulation FD

Mar 24, 2026

Regulation FD Disclosure. On March 25, 2026, Enzon Pharmaceuticals, Inc. issued a press release announcing the completion of the exchange offer relating to its

Peer Companies

Company	Price	Change	Market Cap	P/E
FAMDFFutura Medical plc	—	—	—	—
SRNESorrento Therapeutics, In...	—	—	—	—
CTABFCTABF	—	—	—	—
FNAMEvolutionary Genomics, In...	—	—	—	—
DOSEFDoseology Sciences Inc.	—	—	—	—
CLABFCore One Labs Inc.	—	—	—	—
LIFDLFTD Partners Inc.	—	—	—	—
HLYKHealthLynked Corp.	—	—	—	—

Analyst View

Company Profile

CIK0000727510

ISINUS2939041081

CUSIP293904108

Phone732 980 4500

Address20 Commerce Drive, Cranford, NJ, 07016, US

SEC EDGAR